Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
41.86
-0.32 (-0.76%)
At close: Feb 6, 2026

SHA:603392 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,3402,3883,8195,1931,416710.67
Short-Term Investments
1,250480--20052.54
Trading Asset Securities
1,5392,5102,0552,00940.3950.36
Cash & Short-Term Investments
5,1285,3785,8747,2011,656813.57
Cash Growth
-6.77%-8.44%-18.43%334.83%103.56%134.46%
Accounts Receivable
1,7552,0642,9993,9602,277711.6
Other Receivables
156.6235.9648.715.1512.4513.04
Receivables
1,9122,1043,0533,9702,292724.64
Inventory
831.26863.19905.48869.14593.17400.04
Other Current Assets
120.4729.44469.42139.4105.239.54
Total Current Assets
7,9928,37510,30212,1804,6471,978
Property, Plant & Equipment
3,5403,5382,6412,2351,703790.98
Long-Term Investments
1,1621,36212.01911.361.3211.3
Other Intangible Assets
821.43512.46508.28292.5289.92226.66
Long-Term Deferred Tax Assets
272.44243.33157.9566.0168.9756.49
Long-Term Deferred Charges
211.08363.85214.29172.3727.1827.76
Other Long-Term Assets
371.81294.671,879372.3249.09212.7
Total Assets
14,37114,68915,71516,2307,0463,504
Accounts Payable
470.8137.94234.28275.47154.08107.29
Accrued Expenses
169.49915.891,6532,5721,541440.8
Short-Term Debt
120.59103.6281.14140.14235.6477.66
Current Portion of Long-Term Debt
93.6265.6887.193.07--
Current Portion of Leases
-38.4313.313.7313.93-
Current Income Taxes Payable
14.348.597.4999.02146.554.37
Current Unearned Revenue
90.1748.1570.3882.2870.340.92
Other Current Liabilities
914.98693.76523.42299.34204.64157.98
Total Current Liabilities
1,8742,0122,6703,4852,366829.03
Long-Term Debt
102.3194.19115.36102.494.9-
Long-Term Leases
56.680.9712.3618.4332.59-
Long-Term Unearned Revenue
64.7254.233.6541.3776.4494.26
Long-Term Deferred Tax Liabilities
---17.15--
Other Long-Term Liabilities
----3.8-
Total Liabilities
2,0982,2412,8313,6652,483923.29
Common Stock
1,2651,2651,268906.07607.04433.6
Additional Paid-In Capital
3,1403,1393,3123,729445.83446.27
Retained Earnings
7,7777,9508,2507,9063,4131,674
Treasury Stock
-92.17-92.17-129.42-200.17--
Total Common Equity
12,08912,26312,70112,3414,4662,554
Minority Interest
183.69185.16183.06223.6396.226.73
Shareholders' Equity
12,27312,44812,88412,5654,5622,580
Total Liabilities & Equity
14,37114,68915,71516,2307,0463,504
Total Debt
373.11382.91309.35277.86287.0677.66
Net Cash (Debt)
4,7554,9955,5656,9231,369735.91
Net Cash Growth
-8.94%-10.23%-19.63%405.71%86.03%125.74%
Net Cash Per Share
3.643.764.425.541.110.62
Filing Date Shares Outstanding
1,2651,2651,2681,2681,2321,232
Total Common Shares Outstanding
1,2651,2651,2681,2681,2321,232
Working Capital
6,1186,3637,6328,6952,2811,149
Book Value Per Share
9.569.6910.019.733.622.07
Tangible Book Value
11,26811,75012,19212,0494,1762,327
Tangible Book Value Per Share
8.919.299.619.503.391.89
Buildings
-779.65724.87628.89392.67253.3
Machinery
-1,7641,5101,185666.87565.97
Construction In Progress
-1,469814.56720.51924.38231.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.